Assessment of the Feasibility of Hyperpolarized [1-13 C]pyruvate Whole-Abdomen MRI using D2 O Solvation in Humans

Assessment of the Feasibility of Hyperpolarized [1-¹³ C]pyruvate Whole-Abdomen MRI using D₂ O Solvation in Humans

J Magn Reson Imaging. 2024 Mar 5. doi: 10.1002/jmri.29322. Online ahead of print.

Guannan Zhang¹, Kofi Deh¹, Hijin Park², Charles H Cunningham^{3

4}, Nadia D Bragagnolo⁵, Serge Lyashchenko², Shake Ahmmed², Avigdor Leftin⁵, Elizabeth Coffee⁶, David Kelsen⁷, Hedvig Hricak^{1

8}, Vesselin Miloushev^{1

8}, Marius Mayerhoefer⁹, Kayvan R Keshari^{1

8}

¹ Department of Radiology, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
² Radiochemistry and Molecular Imaging Probes (RMIP) Core, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
³ Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
⁴ Sunnybrook Research Institute, Toronto, Ontario, Canada.
⁵ GE HealthCare, New York City, New York, USA.
⁶ Department of Neurology, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
⁷ Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
⁸ Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
⁹ Department of Radiology, NYU Grossman School of Medicine, New York City, New York, USA.

No abstract available